Skip to main content
PMC home page
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 2001 May-Jun;7(3):434–438. doi: 10.3201/eid0703.010311

Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997.

Y J Hutin 1, R J Williams 1, P Malfait 1, R Pebody 1, V N Loparev 1, S L Ropp 1, M Rodriguez 1, J C Knight 1, F K Tshioko 1, A S Khan 1, M V Szczeniowski 1, J J Esposito 1
PMCID: PMC2631782  PMID: 11384521

Abstract

Human monkeypox is a zoonotic smallpox-like disease caused by an orthopoxvirus of interhuman transmissibility too low to sustain spread in susceptible populations. In February 1997, 88 cases of febrile pustular rash were identified for the previous 12 months in 12 villages of the Katako-Kombe Health Zone, Democratic Republic of Congo (attack rate = 22 per 1,000; case-fatality rate = 3.7%). Seven were active cases confirmed by virus isolation. Orthopoxvirus- neutralizing antibodies were detected in 54% of 72 patients who provided serum and 25% of 59 wild-caught animals, mainly squirrels. Hemagglutination-inhibition assays and Western blotting detected antibodies in 68% and 73% of patients, respectively. Vaccinia vaccination, which protects against monkeypox, ceased by 1983 after global smallpox eradication, leading to an increase in the proportion of susceptible people.

Full Text

The Full Text of this article is available as a PDF (65.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arita I., Jezek Z., Khodakevich L., Ruti K. Human monkeypox: a newly emerged orthopoxvirus zoonosis in the tropical rain forests of Africa. Am J Trop Med Hyg. 1985 Jul;34(4):781–789. doi: 10.4269/ajtmh.1985.34.781. [DOI] [PubMed] [Google Scholar]
  2. Centers for Disease Control and Prevention (CDC) Human monkeypox--Kasai Oriental, Zaire, 1996-1997. MMWR Morb Mortal Wkly Rep. 1997 Apr 11;46(14):304–307. [PubMed] [Google Scholar]
  3. Cherry J. D., McIntosh K., Connor J. D., Benenson A. S., Alling D. W., Rolfe U. T., Todd W. A., Schanberger J. E., Mattheis Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration. Primary percutaneous vaccination. J Infect Dis. 1977 Jan;135(1):145–154. doi: 10.1093/infdis/135.1.145. [DOI] [PubMed] [Google Scholar]
  4. Esposito J. J., Knight J. C. Orthopoxvirus DNA: a comparison of restriction profiles and maps. Virology. 1985 May;143(1):230–251. doi: 10.1016/0042-6822(85)90111-4. [DOI] [PubMed] [Google Scholar]
  5. Fine P. E., Jezek Z., Grab B., Dixon H. The transmission potential of monkeypox virus in human populations. Int J Epidemiol. 1988 Sep;17(3):643–650. doi: 10.1093/ije/17.3.643. [DOI] [PubMed] [Google Scholar]
  6. Jezek Z., Arita I., Mutombo M., Dunn C., Nakano J. H., Szczeniowski M. Four generations of probable person-to-person transmission of human monkeypox. Am J Epidemiol. 1986 Jun;123(6):1004–1012. doi: 10.1093/oxfordjournals.aje.a114328. [DOI] [PubMed] [Google Scholar]
  7. Jezek Z., Grab B., Szczeniowski M. V., Paluku K. M., Mutombo M. Human monkeypox: secondary attack rates. Bull World Health Organ. 1988;66(4):465–470. [PMC free article] [PubMed] [Google Scholar]
  8. Jezek Z., Szczeniowski M., Paluku K. M., Mutombo M., Grab B. Human monkeypox: confusion with chickenpox. Acta Trop. 1988 Dec;45(4):297–307. [PubMed] [Google Scholar]
  9. Khodakevich L., Jezek Z., Messinger D. Monkeypox virus: ecology and public health significance. Bull World Health Organ. 1988;66(6):747–752. [PMC free article] [PubMed] [Google Scholar]
  10. Khodakevich L., Szczeniowski M., Manbu-ma-Disu, Jezek Z., Marennikova S., Nakano J., Messinger D. The role of squirrels in sustaining monkeypox virus transmission. Trop Geogr Med. 1987 Apr;39(2):115–122. [PubMed] [Google Scholar]
  11. Loparev V. N., Parsons J. M., Knight J. C., Panus J. F., Ray C. A., Buller R. M., Pickup D. J., Esposito J. J. A third distinct tumor necrosis factor receptor of orthopoxviruses. Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3786–3791. doi: 10.1073/pnas.95.7.3786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Marennikova S. S., Seluhina E. M., Mal'ceva N. N., Cimiskjan K. L., Macevic G. R. Isolation and properties of the causal agent of a new variola-like disease (monkeypox) in man. Bull World Health Organ. 1972;46(5):599–611. [PMC free article] [PubMed] [Google Scholar]
  13. McIntosh K., Cherry J. D., Benenson A. S., Connor J. D., Alling D. W., Rolfe U. T., Todd W. A., Schanberger J. E., Mattheis M. J. Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration. Standard percutaneous revaccination of children who receive primary percutaneous vaccination. J Infect Dis. 1977 Jan;135(1):155–166. doi: 10.1093/infdis/135.1.155. [DOI] [PubMed] [Google Scholar]
  14. Mukinda V. B., Mwema G., Kilundu M., Heymann D. L., Khan A. S., Esposito J. J. Re-emergence of human monkeypox in Zaire in 1996. Monkeypox Epidemiologic Working Group. Lancet. 1997 May 17;349(9063):1449–1450. doi: 10.1016/S0140-6736(05)63725-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ropp S. L., Jin Q., Knight J. C., Massung R. F., Esposito J. J. PCR strategy for identification and differentiation of small pox and other orthopoxviruses. J Clin Microbiol. 1995 Aug;33(8):2069–2076. doi: 10.1128/jcm.33.8.2069-2076.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ziegler D. W., Hutchinson H. D., Koplan J. P., Nakano J. H. Detection by radioimmunoassay of antibodies in human smallpox patients and vaccinees. J Clin Microbiol. 1975 Mar;1(3):311–317. doi: 10.1128/jcm.1.3.311-317.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES